131 related articles for article (PubMed ID: 30912981)
1. TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells.
Zhang Y; Unnithan RVM; Hamidi A; Caja L; Saupe F; Moustakas A; Cedervall J; Olsson AK
FASEB J; 2019 Jul; 33(7):7822-7832. PubMed ID: 30912981
[TBL] [Abstract][Full Text] [Related]
2. HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment.
Cedervall J; Zhang Y; Ringvall M; Thulin A; Moustakas A; Jahnen-Dechent W; Siegbahn A; Olsson AK
Angiogenesis; 2013 Oct; 16(4):889-902. PubMed ID: 23793459
[TBL] [Abstract][Full Text] [Related]
3. N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-κB/p65.
Hou J; Wang T; Xie Q; Deng W; Yang JY; Zhang SQ; Cai JC
Cancer Lett; 2016 Jun; 376(1):22-33. PubMed ID: 27012186
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1.
Li CW; Xia W; Huo L; Lim SO; Wu Y; Hsu JL; Chao CH; Yamaguchi H; Yang NK; Ding Q; Wang Y; Lai YJ; LaBaff AM; Wu TJ; Lin BR; Yang MH; Hortobagyi GN; Hung MC
Cancer Res; 2012 Mar; 72(5):1290-300. PubMed ID: 22253230
[TBL] [Abstract][Full Text] [Related]
6. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q
Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459
[TBL] [Abstract][Full Text] [Related]
7. shRNA kinome screen identifies TBK1 as a therapeutic target for HER2+ breast cancer.
Deng T; Liu JC; Chung PE; Uehling D; Aman A; Joseph B; Ketela T; Jiang Z; Schachter NF; Rottapel R; Egan SE; Al-Awar R; Moffat J; Zacksenhaus E
Cancer Res; 2014 Apr; 74(7):2119-30. PubMed ID: 24487029
[TBL] [Abstract][Full Text] [Related]
8. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.
Chua HL; Bhat-Nakshatri P; Clare SE; Morimiya A; Badve S; Nakshatri H
Oncogene; 2007 Feb; 26(5):711-24. PubMed ID: 16862183
[TBL] [Abstract][Full Text] [Related]
10. Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling.
Cheng C; Ji Z; Sheng Y; Wang J; Sun Y; Zhao H; Li X; Wang X; He Y; Yao J; Wang L; Zhang C; Guo Y; Zhang J; Gao WQ; Zhu HH
Theranostics; 2018; 8(17):4633-4648. PubMed ID: 30279728
[TBL] [Abstract][Full Text] [Related]
11. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
12. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
Serrano I; McDonald PC; Lock FE; Dedhar S
Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
[TBL] [Abstract][Full Text] [Related]
13. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor α induces epithelial-mesenchymal transition and promotes metastasis via NF-κB signaling pathway-mediated TWIST expression in hypopharyngeal cancer.
Yu L; Mu Y; Sa N; Wang H; Xu W
Oncol Rep; 2014 Jan; 31(1):321-7. PubMed ID: 24220622
[TBL] [Abstract][Full Text] [Related]
15. Blocking TBK1 alleviated radiation-induced pulmonary fibrosis and epithelial-mesenchymal transition through Akt-Erk inactivation.
Qu H; Liu L; Liu Z; Qin H; Liao Z; Xia P; Yang Y; Li B; Gao F; Cai J
Exp Mol Med; 2019 Apr; 51(4):1-17. PubMed ID: 30988282
[TBL] [Abstract][Full Text] [Related]
16. Autocrine PDGFR signaling promotes mammary cancer metastasis.
Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition.
Zhang Q; Han M; Wang W; Song Y; Chen G; Wang Z; Liang Z
Oncol Rep; 2015 Apr; 33(4):1851-9. PubMed ID: 25632968
[TBL] [Abstract][Full Text] [Related]
18. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
19. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
Pomerantz JL; Baltimore D
EMBO J; 1999 Dec; 18(23):6694-704. PubMed ID: 10581243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
